Biography
Dr Shivanshan (Shiv) Pathmanathan is passionate about providing patient-centred care with a personalised, evidence-based approach to treatment. With a deep understanding of the impact a cancer diagnosis can have, he delivers holistic care that reflects his patients’ individual needs and preferences.
Dr Shiv Pathmanathan is a medical oncologist at Icon Cancer Centre Townsville. In 2012 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at James Cook University and subsequently undertook specialist medical oncology training at various Brisbane, Gold Coast and North Queensland hospitals and tertiary oncology centres. During his training, Dr Pathmanathan gained extensive experience in the management of a broad range of solid tumour malignancies in a multidisciplinary environment. He is a fellow of the Royal Australasian College of Physicians (FRACP).
Dr Pathmanathan maintains a strong commitment to improving models of care for patients, with a particular interest in geriatric patient management and enhancing access to cancer care for vulnerable patient groups. He is actively involved in medical education, clinical research and trials, contributing to several peer-reviewed publications and EVIQ protocols and presenting at national and international conferences. His presentations include multi-centre collaborative research in management of melanoma in elderly patients, cancer management in elderly patients, and the administration of chemotherapy in rural areas. Dr Pathmanathan is also involved the teaching of medical students, junior doctors and advanced trainees.
His clinical experience covers a wide range of solid tumour malignancies, with a special interest in breast cancer, skin cancer including melanoma, genitourinary cancer, gastrointestinal cancer and geriatric oncology.
Publications
Pathmanathan, S., Babu, H., Dzienis, M., et al. (2022). Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis. Pigment cell & melanoma research, 35(6), 587–594.
Pathmanathan, S., Tariq, A., Gan, C., et al. (2022) Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC). Journal of Clinical Oncology, 40(16), 4540-4540.
Pathmanathan, S., Sanmugarajah, J., & Niranjan, S. (2019) Cardiotoxicity secondary to breast cancer chemotherapy. Sri Lankan Journal of Cardiology, 1(2) 24-29.
Verma, R., Pathmanathan, S., Otty, Z. A., et al. (2018). Delays in lung cancer management pathways between rural and urban patients in North Queensland: a mixed methods study. Internal medicine journal, 48(10), 1228–1233.
Ladwa, R., Kalas, T., Pathmanathan, S., et al. (2018). Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer. Clinical breast cancer, 18(5), e1181–e1187.
Pathmanathan S, Burgher B & Sabesan S. Is Intensive chemotherapy safe for rural cancer patients. Internal Medicine Journal, 43(6), 643-649.